Jill Ohar, M.D., Professor Internal Medicine-Pulmonary, Critical Care, Allergy, and Immunologic Medicine

Jill Ohar, M.D.

Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine
Center for Genomics and Personalized Medicine Research
Comprehensive Cancer Center
Center for Worker Health
Center for Genomics and Personalized Medicine Research

Clinical Specialties

General Pulmonary Diseases, Lung Cancer, Chronic Obstructive Pulmonary Disease (COPD), Occupational Lung Disease

Contact Information

Department: 336-716-2011

Education & Training

M.D., Med Coll Of Pennsylvania , 1977
B.S., Muhlenberg College , 1973
Internship, Medicine, V.A. Hospital, 1979
Internship, Medicine, Med Coll Virginia Hosps, 1981
Fellowship, Medicine, Medical Coll Of Virginia, 1985

Board Certifications

American Board of Internal Medicine

Memberships

Nat'L Board Of Medical Examine
Amer Coll Of Chest Physicians
Am Coll Of Physicians
American Thoracic Society

NPI Number

1376526400

Jill Ohar, M.D.

Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine Center for Genomics and Personalized Medicine Research
Comprehensive Cancer Center
Center for Worker Health
Center for Genomics and Personalized Medicine Research

Research Interests

genetics/genome, health services, research/outc

Contact Information

Academic: 336-716-4843 | Department: 336-716-2011

Recent Publications

Miles MC, Donohue JF, Ohar JA. Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?. Drugs. 2012;72(3):301-308.

Miles MC, Donohue JF, Ohar JA. Combination therapy for COPD: emerging evidence from recent clinical trials. Clin Investig (Lond). 2011;1(6):879-890.

Ohar J, Fromer L, Donohue JF. Reconsidering sex-based stereotypes of COPD. Prim Care Respir J. 2011;20(4):370-378.

Ohar JA, Sadeghnejad A, Meyers DA, Donohue JF, Bleecker ER. Do symptoms predict COPD in smokers?. Chest. 2010;137(6):1345-1353.

Ohar JA, Hamilton RF Jr, Zheng S, Sadeghnejad A, Sterling DA, Xu J, Meyers DA, Bleecker ER, Holian A. COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest. 2010;137(5):1098-1107.

Sadeghnejad A, Ohar JA, Bleecker ER, Meyers D. Replication of an association of the interleukin-1 receptor antagonist gene with asthma in an adult urban admixed population [abstract]. Am J Respir Crit Care Med. 2010;181(1 Meeting Abstracts):A3877.

Ohar JA, Howard TD, Ampleford EJ, Bleecker ER, Meyers DA. Genome wide association study in mesothelioma [abstract]. Am J Respir Crit Care Med. 2010;181(1 Meeting Abstracts):A4340.

Ohar JA, Donohue JF. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD. Semin Respir Crit Care Med. 2010;31(3):321-333.

Sadeghnejad A, Ohar JA, Zheng SL, Sterling DA, Hawkins GA, Meyers DA, Bleecker ER. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. Respir Res. 2009;10():article 21.

Sadeghnejad A, Koppelman GH, Ohar JA, Postma DS, Bleecker ER, Meyers DA. Role of SERPINE2 in asthma and COPD [abstract]. Am J Respir Crit Care Med. 2009;179(Online Abstr Issue):A2741.

Ohar JA, Sadeghnejad A, Meyers DA, Bleecker ER. Symptoms poorly predict the presence of COPD in at-risk smokers [abstract]. Am J Respir Crit Care Med. 2009;179(Online Abstr Issue):A1471.

Schunemann HJ, Osborne M, Moss J, Manthous C, Wagner G, Sicilian L, Ohar J, McDermott S, Lucas L, Jaeschke R. An official American Thoracic Society policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med. 2009;180(6):564-580.

Cazzola M, Hanania NA, Jones PW, Mahler DA, Make B, Ohar J, Rennard S. It's about time--directing our attention toward modifying the course of COPD. J Respir Med. 2008;102(Suppl 1):S37-S48.

Ohar JA, Holian A, Sadeghnejad A, Hamilton RF, Zheng SL, Xu J, Meyers DA, Bleecker ER. Polymorphisms in MSR1 gene affect macrophage function [abstract]. Am J Respir Crit Care Med. 2008;177(Online Abstr Issue):A503.

Sadeghnejad A, Ohar JA, Zheng SL, Hawkins GA, Meyers DA, Bleecker ER. ADAM33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers [abstract]. Am J Respir Crit Care Med. 2008;177(Online Abstr Issue):A504.

Ohar JA, Ampleford EJ, Howard SE, Sterling DA. Identification of a mesothelioma phenotype. Respir Med. 2007;101(3):503-509.

Sadeghnejad A, Meyers DA, Bleeker [sic] ER [Bleecker ER], Ohar JA. IL13 promoter polymorphism enhances the adverse effect of smoking on lung function [abstract]. Am J Respir Crit Care Med. 2007;175(Abstr Issue):A563.

Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, Ohar JA. IL13 promoter polymorphism -1112C/T modulates the adverse effect of tobacco smoking on lung function. Am J Respir Crit Care Med. 2007;176(8):748-752.

Ampleford EJ, Ohar J. Mesothelioma: you do not have to work for it. Diagn Cytopathol. 2007;35(12):774-777.

Ohar J, McCallister J. Smoking trends have led to increased mortality: COPD in women, part 1: a review of recent trends. J Respir Dis. 2006;27(2):70-74.

Ohar J, McCallister J. Should sex differences affect the approach to treatment? COPD in women, part 2: treatment considerations. J Respir Dis. 2006;27(3):115-122.

Ohar JA, Ampleford EJ, Sterling DA, Bleecker ER, Meyers DA. ADAM33 is associated with COPD in a large US population [abstract]. In: American Thoracic Society International Conference Abstracts; 2006 May 19-24; San Diego (CA). 2006;():A620.